Withings Health Solutions’ Body Pro 2
Detecting Diabetic Foot Ulcers
Withings Health Solutions’ newest addition to its connected health ecosystem is Body Pro 2, the next-gen cellular smart scale that launched in November 2023. Leveraging years of research and development, Body Pro 2 is the result of consultation with hundreds of digital health partners and clinicians. It combines habit-forming user features with a pioneering modular approach to manage chronic conditions. Its core capabilities allow care teams to capture advanced health metrics such as weight and body composition while additional and optional health modules unlock the ability to track advanced and clinically validated biomarkers typically only available in a professional setting.
The first module is prescription-only and aims to improve the care of patients with diabetes. With this module, care teams can better monitor one of the biggest yet often overlooked diabetes complications, diabetic foot health. By monitoring patients’ Electrochemical Skin Conductance (ESC), the scale may help to detect early signs of Diabetic Peripheral Neuropathies (DPN) and may help to assess the risk for diabetic foot ulcers.
The scale also includes several patient engagement features such as personalized health nudges (in which care teams can send tailored messages to patients through the dynamic color screen) and eyes closed mode (which can hide weight readings but still offer motivational messages that encourage positive progress for patients who don’t want to see their weight). Meanwhile, the ProgramMemberID feature provides care teams assurance, based on a score (0-100%), of the likelihood that the measurement reading came from their patients, rather than from one of their family members. Additionally, an engagement score helps care teams understand their patients’ level of engagement.
